Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.220
-0.060 (-4.69%)
At close: Mar 9, 2026, 4:00 PM EDT
1.220
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:26 PM EDT
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,554,496
Market Cap
2.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2021 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2020 | 2 | 1 | 100.00% | 1 | 1 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| Scinai Immunotherapeutics | 31 |
| Lyra Therapeutics | 30 |
| Ensysce Biosciences | 8 |
| Artelo Biosciences | 7 |
| CDT Equity | 6 |
| Enveric Biosciences | 6 |
| Adial Pharmaceuticals | 5 |
BBLG News
- 2 months ago - Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook - GlobeNewsWire
- 2 months ago - Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months - GlobeNewsWire
- 6 months ago - Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook - Business Wire
- 6 months ago - Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference - Business Wire
- 9 months ago - Bone Biologics Announces Closing of $5.0 Million Public Offering - Business Wire
- 9 months ago - Why Is Bone Biologics Stock Surging On Friday? - Benzinga
- 9 months ago - Bone Biologics Announces Pricing of $5.0 Million Public Offering - Business Wire
- 9 months ago - Bone Biologics Files Patent Application for Bone Regeneration Technology - Business Wire